ConductScience.org, home

Paper2196554

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

Männistö PT and 1 other. Pharmacol Toxicol, 1990. Cited by 130 papers, by iCite.

Cite this record

ConductScience Library. Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. Papers, record 2196554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2196554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.
PubMed
Journal
Pharmacol Toxicol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
5.74
iCite
Revised in PubMed
2019-09-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Männistö PTP T
2Kaakkola SS

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Catechol O-Methyltransferase InhibitorsMajor topic
Parkinson DiseaseMajor topic
Animals
Humans

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
42014471Impact of catechol-O-methyltransferase inhibition on plasma homocysteine levels in levodopa-treated Parkinson's disease.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42014471PubMed
33675481Entacapone scavenges peroxynitrite and protects against kidney and liver injuries induced by renal ischemia/reperfusion in rats.Int Urol Nephrol2021https://conductscience.org/library/papers/33675481PubMed
30824559Increased dose of carbidopa with levodopa and entacapone improves "off" time in a randomized trial.Neurology2019https://conductscience.org/library/papers/30824559PubMed
28289795[Pharmacological treatment of motor symptoms in Parkinson's diseases].Nervenarzt2017https://conductscience.org/library/papers/28289795PubMed
27520516Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease.CNS Drugs1994https://conductscience.org/library/papers/27520516PubMed
24460628Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator.BMC Med Genomics2014https://conductscience.org/library/papers/24460628PubMed
19628038NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.J Steroid Biochem Mol Biol2009https://conductscience.org/library/papers/19628038PubMed
17894650Catechol-O-methyltransferase and its inhibitors in Parkinson's disease.CNS Drug Rev2007https://conductscience.org/library/papers/17894650PubMed
12959293The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise.Br J Clin Pharmacol1993https://conductscience.org/library/papers/12959293PubMed
11994054Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin.Br J Clin Pharmacol2002https://conductscience.org/library/papers/11994054PubMed
10882160Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease.Drugs2000https://conductscience.org/library/papers/10882160PubMed
10516661Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.Br J Pharmacol1999https://conductscience.org/library/papers/10516661PubMed
10510160COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet).Br J Clin Pharmacol1999https://conductscience.org/library/papers/10510160PubMed
10408739Does levodopa accelerate Parkinson's disease?Drugs Aging1999https://conductscience.org/library/papers/10408739PubMed
10323601In vivo effects of new inhibitors of catechol-O-methyl transferase.Br J Pharmacol1999https://conductscience.org/library/papers/10323601PubMed
9203084Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease.J Neural Transm (Vienna)1997https://conductscience.org/library/papers/9203084PubMed
8877311New directions in the drug treatment of Parkinson's disease.Drugs Aging1996https://conductscience.org/library/papers/8877311PubMed
8785021Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.J Neural Transm Gen Sect1995https://conductscience.org/library/papers/8785021PubMed
8527287Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8527287PubMed
8126502Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.J Neurol Neurosurg Psychiatry1994https://conductscience.org/library/papers/8126502PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2196554

GET https://conductscience.org/api/papers/v1/2196554/cited_by?page=2